Taleen Hanania

Affiliations: 
PsychoGenics Inc, Tarrytown, NY, United States 
Area:
CNS disorders
Google:
"Taleen Hanania"
Mean distance: 19.53 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shao L, Campbell UC, Fang QK, et al. (2016) In vivo phenotypic drug discovery: Applying a behavioral assay to the discovery and optimization of novel antipsychotic agents Medchemcomm. 7: 1093-1101
Brunner D, Kabitzke P, He D, et al. (2015) Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder. Plos One. 10: e0134572
Alexandrov V, Brunner D, Hanania T, et al. (2015) Reprint of: Highthroughtput analysis of behavior for drug discovery. European Journal of Pharmacology. 753: 127-34
Alexandrov V, Brunner D, Hanania T, et al. (2015) High-throughput analysis of behavior for drug discovery. European Journal of Pharmacology. 750: 82-9
Chang Q, Hanania T, Mash DC, et al. (2015) Noribogaine reduces nicotine self-administration in rats Journal of Psychopharmacology. 29: 704-711
Hanson JE, La H, Plise E, et al. (2013) SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. Plos One. 8: e69964
Zhang HK, Yu LF, Eaton JB, et al. (2013) Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II. Journal of Medicinal Chemistry. 56: 5495-504
Gunosewoyo H, Midzak A, Gaisina IN, et al. (2013) Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesis. Journal of Medicinal Chemistry. 56: 5115-29
Yu LF, Eaton JB, Fedolak A, et al. (2012) Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part II. Journal of Medicinal Chemistry. 55: 9998-10009
Zhang HK, Eaton JB, Yu LF, et al. (2012) Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands. Journal of Medicinal Chemistry. 55: 8028-37
See more...